ClinVar Miner

Submissions for variant NM_001367624.2(ZNF469):c.1609G>A (p.Val537Met)

gnomAD frequency: 0.00172  dbSNP: rs184458982
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000488174 SCV000491492 likely benign not provided 2020-12-18 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 29228253)
CeGaT Center for Human Genetics Tuebingen RCV000488174 SCV000575064 likely benign not provided 2024-04-01 criteria provided, single submitter clinical testing ZNF469: BP4
Eurofins Ntd Llc (ga) RCV000488174 SCV000703606 uncertain significance not provided 2016-12-13 criteria provided, single submitter clinical testing
Invitae RCV000488174 SCV002475552 likely benign not provided 2024-01-31 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002278643 SCV002565283 likely benign Ehlers-Danlos syndrome 2021-08-13 criteria provided, single submitter clinical testing
Ambry Genetics RCV002402101 SCV002706461 benign Cardiovascular phenotype 2021-08-05 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Revvity Omics, Revvity RCV003137993 SCV003821857 uncertain significance Brittle cornea syndrome 1 2022-06-21 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003902458 SCV004723391 uncertain significance ZNF469-related disorder 2023-12-09 criteria provided, single submitter clinical testing The ZNF469 c.1609G>A variant is predicted to result in the amino acid substitution p.Val537Met. This variant was reported in individuals with keratoconus and corneal dystrophy (Lucas et al. 2017. PubMed ID: 29228253; Li et al. 2021. PubMed ID: 33816482). This variant is reported in 0.27% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000488174 SCV001808486 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000488174 SCV001967295 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.